A Patient With CD20-positive T-cell Lymphoma Concurrently Exhibiting B-cell Neoplasm-related Genetic Abnormalities Shows Clonal Escape Post CD20-targeting Treatment

참고문헌 (10)

1. Yao X, "Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20 : a diagnostic pitfall", Mod Pathol, 14, pp.105~110 (2001)
2. Mangogna A, "Rituximab plus chemotherapy provides no clinical benefit in a peripheral T-cell lymphoma not otherwise specified with aberrant Expression of CD20 and CD79a: a case report and review of the literature", Diagnostics (Basel), 10, pp.341~ (2020)
3. Imai M, "CD20-positive T-cell lymphoma involving bone marrow : report of four cases", J Hematopathol, 6, pp.201~205 (2013)
4. Manso R, "Recurrent presence of the PLCG1 S345F mutation in nodal peripheral T-cell lymphomas", Haematologica, 100, pp.e25~7 (2015)
5. "The Atlas of Genetics and Cytogenetics in Oncology and Haematology"[URL]
6. Magro CM, "Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement", Am J Clin Pathol, 126, pp.14~22 (2006)
7. Zhang Y, "Primary breast CD20-positive extranodal NK", T cell lymphoma with stomach involvement : a case report and literature review, 2021, pp.16, 103~
8. Lazzi S, "Rare lymphoid neoplasms coexpressing B- and T-cell antigens. The role of PAX-5 gene methylation in their pathogenesis", Hum Pathol, 40, pp.1252~1261 (2009)
9. van Dongen JJ, "Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations : report of the BIOMED-2 Concerted Action BMH4-CT98-3936", Leukemia, 17, pp.2257~2317 (2003)
10. Shao Y, "T-cell lymphoma with abundant CD20 expression showing a good response to rituximab with gemcitabine, oxiplatin, and L-asparaginase (R-pGEMOX): A case report", Medicine(Baltimore), 97, pp.e0199~ (2018)

관련 논문AI추천